Company intelligence / Profile preview

Rigel Dermatology

Dallas, Texas, United Statesdrrigel.com ↗

Ownership: Public · RIGL
Development stage: Commercial

Overview

Rigel Dermatology, led by Dr. Darrell S. Rigel, provides specialized care in melanoma and other skin cancers with a focus on prevention, early detection, diagnosis, treatment—including surgery—and education for both patients and clinicians. The clinic has contributed significantly to public health through research (notably co-authoring the “ABCDEs of Early Melanoma Detection”) and ongoing leadership in national dermatologic organizations.

Therapeutic areas: OncologyDermatology
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Cooper Clinic (Dallas)

Financials

Market cap: $874.8M
Total revenue: $78.7M
Enterprise value: $819.4M

Beyond the preview

Go deeper on Rigel Dermatology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rigel Dermatology.

Explore the full profile